ChiCTR2000041476: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE-DOSE STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PADSEVONIL IN HEALTHY CHINESE SUBJECTS |
|
|
| Recruiting | 1 | 14 | | Padsevonil(PSL) 200 mg ;placebo | West China Hospital, Sichuan University; UCB Biopharma SPRL, UCB Biopharma SPRL | epilepsy | | | | |
